Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas

Contraception

Volumn 84, Issue 5, 2011, Pages

  Bahamondes, M Valeria ^a   Hidalgo, M Margarete ^a   Bahamondes, Luis ^a   Monteiro, Ilza ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Insertion; Levonorgestrel releasing intrauterine system; Mirena; Nulligravida women; Parous women

Indexed keywords

LEVONORGESTREL; MISOPROSTOL; WARFARIN;

ADULT; ARTICLE; BLEEDING; ENDOMETRIOSIS; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAUTERINE DEVICE EXPULSION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; NORMAL HUMAN; NULLIPARA; OUTCOME ASSESSMENT; PREGNANCY RATE; TREATMENT FAILURE;

ADULT; BRAZIL; CLINICAL COMPETENCE; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; PARITY; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 80054729305     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.05.012     Document Type: Article

References (38)

1. C. d'Arcangues Worldwide use of intrauterine devices for contraception Contraception 75 6 Suppl 2007 S2 S7
2. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction: task force on the safety and efficacy of fertility regulating methods. The TCu380A, TCu220C, Multiload 250 and Nova T IUDS at 3, 5 and 7 years of use-results from three randomized multicenter trials Contraception 42 1990 141 158
3. T. Luukkainen, and J. Toivonen Levonorgestrel-releasing intrauterine IUD as a method of contraception with therapeutic properties Contraception 52 1995 269 276
4. The Guttmacher Institute Facts on contraceptive use Jan 2008 Available at: http://www.guttmacher.org/pubs/fb-contr-use.pdf (Accessed September 2010)
5. K. Wellings, Z. Zhihong, A. Krentel, G. Barretta, and A. Glasier Attitudes towards long-acting reversible methods of contraception in general practice in the UK Contraception 76 2007 208 214 (Pubitemid 47247663)
6. N.L. Stanwood, J.M. Garrett, and T.R. Konrad Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice Obstet Gynecol 99 2002 275 280 (Pubitemid 34114001)
7. K.I. Black, T. Sakhaei, and S.M. Garland A study investigating obstetricians' and gynaecologists' management of women requesting an intrauterine device Aust N Z J Obstet Gynaecol 50 2010 184 188
8. D.A. Grimes Forgettable contraception Contraception 80 2009 497 499
9. L. Bahamondes, A. Faundes, B. Sobreira-Lima, J.F. Lui-Filho, P. Pecci, and S. Matera TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age Contraception 72 2005 337 341 (Pubitemid 41503129)
10. I. Sivin Utility and drawbacks of continuous use of a copper T IUD for 20 years Contraception 75 6 Suppl 2007 S70 S75
11. M.M. Hidalgo, C. Hidalgo-Regina, M.V. Bahamondes, I. Monteiro, C.A. Petta, and L. Bahamondes Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system Contraception 80 2009 84 89
12. Paragard intrauterine copper contraceptive. Prescribing information. http://www.paragard.com/health-care-professional/global/pdf/Prescribing-Info. pdf Accessed on September 2010.
13. Mirena® highlights of prescribing information. http://berlex. bayerhealthcare.com/html/products/pi/Mirena-PI.pdf Accessed on September 2010.
14. World Health Organization Medical eligibility criteria for contraceptive use http://www.who.int/reproductivehealth/publications/family-planning/ 9789241563888/en/ Accessed on September 2010
15. S. Suhonen, M. Haukkamaa, T. Jakobsson, and I. Rauramo Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study Contraception 69 2004 407 412 (Pubitemid 38510332)
16. A. Brockmeyer, M. Kishen, and A. Webb Experience of IUD/IUS insertions and clinical performance in nulliparous women - a pilot study Eur J Contracept Reprod Health Care 13 2008 248 254
17. R. Lyus, P. Lohr, S. Prager Board of the Society of Family Planning Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women Contraception 81 2010 367 371
18. C. Tietze, and S. Lewit Recommended procedures for the statistical evaluation of intrauterine contraception Stud Fam Plann 4 1973 35 42
19. L. Zhou, M. Harrison-Woolrych, and D.M. Coulter Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena) Pharmacoepidemiol Drug Saf 12 2003 371 377 (Pubitemid 36903371)
20. I. Sivin, S. el Mahgoub, and T. McCarthy Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study Contraception 42 1990 361 378 [Erratum in: Contraception 1991;43:100] (Pubitemid 20312978)
21. L.W. Chien, W.M. Liu, C.R. Tzeng, and H.K. Au Effect of previous live birth and prior route of delivery on the outcome of early medical abortion Obstet Gynecol 113 2009 669 674
22. D. Ofili-Yebovi, J. Ben-Nagi, and E. Sawyer Deficient lower-segment Cesarean section scars: prevalence and risk factors Ultrasound Obstet Gynecol 31 2008 72 77 (Pubitemid 351211934)
23. S.W. Ngai, Y.M. Chan, O.S. Tang, and P.C. Ho The use of misoprostol for pre-operative cervical dilatation prior to vacuum aspiration: a randomized trial Hum Reprod 14 1999 2139 2142 (Pubitemid 29381259)
24. S.W. Ngai, O.S. Tang, and P.C. Ho Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy Hum Reprod 15 2000 2205 2208
25. I. Sääv, A. Aronsson, L. Marions, O. Stephansson, and K. Gemzell-Danielsson Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial Hum Reprod 22 2007 2647 2652 (Pubitemid 47434207)
26. O. Heikinheimo, P. Inki, and M. Kunz Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system Contraception 81 2010 481 486
27. H. El-Refaey, D. Rajasekar, M. Abdalla, L. Calder, and A. Templeton Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol N Engl J Med 332 1995 983 987
28. Measure DHS. Demographic and health surveys. www.measuredhs.com/pubs/pub details.cfm?ID=119&srchTp=. Accessed on September 2010.
29. A.M. Kaunitz, F. Bissonnette, I. Monteiro, E. Lukkari-Lax, C. Muysers, and J.T. Jensen Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial Obstet Gynecol 116 2010 625 632 [Erratum in: Obstet Gynecol 2010;116:999]
30. I.S. Fraser Non-contraceptive health benefits of intrauterine hormonal systems Contraception 82 2010 396 403
31. C.A. Petta, R.A. Ferriani, and M.S. Abrão A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system Eur J Obstet Gynecol Reprod Biol 143 2009 128 129
32. A.Y.K. Wong, L.C.H. Tang, and R.K.H. Chin Levonorgestrel-releasing intrauterine system (Mirena®) and depot medroxyprogesterone acetate (DepoProvera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial Aust N Z J Obstet Gynaecol 50 2010 273 279
33. M. Teitelman, C.A. Grotegut, N.N. Williams, and J.D. Lewis The impact of bariatric surgery on menstrual patterns Obes Surg 16 2006 1457 1463 (Pubitemid 44759978)
34. D.V. Avgerinos, O.H. Llaguna, M. Seigerman, A.J. Lefkowitz, and I.M. Leitman Incidence and risk factors for the development of anemia following gastric bypass surgery World J Gastroenterol 16 2010 1867 1870
35. K.R. Culwell, K.M. Curtis, and M. del Carmen Cravioto Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review Obstet Gynecol 114 2009 341 353
36. M.E. Paulen, S.G. Folger, K.M. Curtis, and D.J. Jamieson Contraceptive use among solid organ transplant patients: a systematic review Contraception 82 2010 102 112
37. J. Diaz, L. Bahamondes, I. Monteiro, C. Petta, M.M. Hildalgo, and X.E. Arce Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena) in Campinas, Brazil Contraception 62 2000 59 61
38. T. Backman, S. Huhtala, R. Luoto, J. Tuominen, I. Rauramo, and M. Koskenvuo Advance information improves user satisfaction with the levonorgestrel intrauterine system Obstet Gynecol 99 2002 608 613 (Pubitemid 34246299)